209 related articles for article (PubMed ID: 10570642)
1. [Adverse event after BCG vaccination in Poland in the years 1994-1997].
Szczuka I
Pneumonol Alergol Pol; 1999; 67(5-6):208-16. PubMed ID: 10570642
[TBL] [Abstract][Full Text] [Related]
2. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
Szczuka I
Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
[TBL] [Abstract][Full Text] [Related]
3. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
[TBL] [Abstract][Full Text] [Related]
4. [BCG vaccination: characteristics of drugs and causes of vaccinal complications].
Levi DT; Aksenova VA; Zakirova NR; Aleksandrova NV
Probl Tuberk; 1999; (4):4-7. PubMed ID: 10479921
[TBL] [Abstract][Full Text] [Related]
5. The rate of adverse events following BCG vaccination in Poland.
Krysztopa-Grzybowska K; Paradowska-Stankiewicz I; Lutyńska A
Przegl Epidemiol; 2012; 66(3):465-9. PubMed ID: 23230718
[TBL] [Abstract][Full Text] [Related]
6. Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia.
Al-Salem AH; Kothari MR; AlHani HM; Oquaish MM; Khogeer SS; Desouky MS
Saudi Med J; 2012 Feb; 33(2):172-6. PubMed ID: 22327758
[TBL] [Abstract][Full Text] [Related]
7. BCG vaccine-associated suppurative lymphadenitis.
Teo SS; Smeulders N; Shingadia DV
Vaccine; 2005 Apr; 23(20):2676-9. PubMed ID: 15780451
[TBL] [Abstract][Full Text] [Related]
8. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
[TBL] [Abstract][Full Text] [Related]
9. [Adverse events following BCG vaccination].
Sagić L
Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
[TBL] [Abstract][Full Text] [Related]
10. An outbreak of BCG related lymphadenitis in Malaysian infants.
Hooi LN; Athiyah SO
Med J Malaysia; 1994 Dec; 49(4):327-35. PubMed ID: 7674967
[TBL] [Abstract][Full Text] [Related]
11. BCG vaccination of neonates, infants, schoolchildren and adolescents. Part II: Safety of a vaccine with strain 1331 Copenhagen.
Lehmann HG; Engelhardt H; Freudenstein H; Hennessen W; Quast U; Widmark RM
Dev Biol Stand; 1979; 43():133-6. PubMed ID: 520665
[TBL] [Abstract][Full Text] [Related]
12. Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI(®) in Singapore.
Soh SB; Han PY; Tam KT; Yung CF; Liew WK; Tan NW; Chong CY; Thoon KC
Vaccine; 2014 Oct; 32(44):5809-15. PubMed ID: 25173482
[TBL] [Abstract][Full Text] [Related]
13. Control of an outbreak of BCG complications in Gaza.
Daoud W
Respirology; 2003 Sep; 8(3):376-8. PubMed ID: 12911834
[TBL] [Abstract][Full Text] [Related]
14. [Regional suppurative lymphadenitis after BCG vaccination (author's transl)].
Brehmer W; Falkenberg N; Hussels H; Otto HS; Preussler H; Waldschmidt J
Dtsch Med Wochenschr; 1977 Sep; 102(35):1251-5. PubMed ID: 902587
[TBL] [Abstract][Full Text] [Related]
15. Needle aspiration as a diagnostic tool and therapeutic modality in suppurative lymphadenitis following Bacillus Calmette Guerin vaccination.
Sataynarayana S; Mathur AD; Verma Y; Pradhan S; Bhandari MK
J Assoc Physicians India; 2002 Jun; 50():788-91. PubMed ID: 12240843
[TBL] [Abstract][Full Text] [Related]
16. [Safety BCG vaccinations--adverse effects following immunization. Part I. Types, occurrence and registrations].
Szczuka I
Przegl Epidemiol; 2002; 56(1):1-13. PubMed ID: 12150052
[TBL] [Abstract][Full Text] [Related]
17. Significance of the number of viable units in BCG vaccines.
Nyerges G; Drinóczy M
Dev Biol Stand; 1986; 58 ( Pt A)():331-6. PubMed ID: 3297870
[TBL] [Abstract][Full Text] [Related]
18. [Comparative evaluation of the effectiveness of vaccination of newborn infants with BCG and BCG-M vaccines].
Mitinskaia LA; Demeshko ND; Efimova AA; Litseva OA; Iablokova TB; Levi DT; Pisarenko NN; Kogan ES
Probl Tuberk; 1990; (12):3-5. PubMed ID: 2084688
[TBL] [Abstract][Full Text] [Related]
19. [Safety of BCG vaccinations--adverse effects following immunization. Part II. Causes of complications. Clinical management].
Szczuka I
Przegl Epidemiol; 2002; 56(1):15-28. PubMed ID: 12150058
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors in the development of complications after BCG vaccination].
Kozlova AV
Probl Tuberk; 1984 Aug; (8):15-9. PubMed ID: 6494116
[No Abstract] [Full Text] [Related]
[Next] [New Search]
